Use of infliximab in the treatment of Crohn's disease in children and adolescents

J Pediatr Gastroenterol Nutr. 2001 Sep:33 Suppl 1:S36-9. doi: 10.1097/00005176-200109001-00006.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Child
  • Crohn Disease / drug therapy*
  • Crohn Disease / physiopathology
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab